Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05624528
PHASE2

A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder

Sponsor: University of Chicago

View on ClinicalTrials.gov

Summary

The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.

Official title: A Double-Blind, Randomized, Placebo-Controlled Study of Tolcapone for OCD

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

49

Start Date

2023-06-22

Completion Date

2026-06

Last Updated

2026-03-10

Healthy Volunteers

No

Interventions

DRUG

Tolcapone

catechol-O-methyl transferase inhibitor

DRUG

Placebo

Pill that contains no medicine

Locations (1)

University of Chicago Medical Center

Chicago, Illinois, United States